Global Endoprosthesis Market Insights Forecasts to 2033

• The Global Endoprosthesis Market Size was Valued at USD 23.58 Billion in 2023
• The Market Size is Growing at a CAGR of 11.10% from 2023 to 2033
• The Worldwide Endoprosthesis Market Size is Expected to Reach USD 67.58 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Endoprosthesis Market Size is Anticipated to Exceed USD 67.58 Billion by 2033, Growing at a CAGR of 11.10% from 2023 to 2033.  

Market Overview

Endoprosthesis is an artificial device implanted inside the body to replace a lost body portion. A prosthetic joint called an endoprosthesis is implanted during surgery to replace a broken joint. The hip, knee, and shoulder joints are the most frequently operated on joints. Total joint replacement, or TEP, refers to the replacement of the whole joint. Patients with severe forms of arthritis or other joint diseases typically benefit from artificial joint replacement. Even after taking painkillers, the discomfort did not go away, and conservative non-surgical treatment was ineffective. An endoprosthesis typically denotes a permanent solution to the afflicted joint's issue, since total knee or hip replacements can endure up to 20 years, and sometimes longer. Technological developments in endoprosthesis devices and rising public awareness of endoprosthesis are driving growth in the global endoprosthesis market. Furthermore, the worldwide endoprosthesis market is growing due to factors like the increased prevalence of cardiovascular disorders and orthopedic injury incidence. Throughout the forecast period, increased healthcare expenditures by both public and private entities, together with the rising incidence of chronic diseases including cancer, heart disease, and arthritis, are expected to be major market drivers driving demand for endoprosthesis.

Report Coverage

This research report categorizes the market for the endoprosthesis market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the endoprosthesis market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the endoprosthesis market.

Driving Factors

The increasing cases of cardiovascular disorders, like coronary artery disease and heart valve diseases are propelling the demand for endoprosthesis, such as stents, pacemakers, and heart valves. Furthermore, the rising geriatric population around the world, which is more vulnerable to orthopedic disorders, osteoporosis, osteopenia, and osteoarthritis is predicted to propel the demand for endoprosthesis implants. In addition, ongoing technological advancements lead to enhanced success rates, reduced risk, minimized recovery time, and the development of patient-specific customized implants is holding up the market growth. Additionally, approving healthcare insurance policies and healthcare reforms focusing on developing healthcare infrastructure available and affordable for all is predicted to enhance the adoption rate of endoprosthesis.

Restraining Factors

The high expenses of endoprosthesis implants, such as cardiac stents and knee implants is a key factor hindering market growth, particularly in developing countries. Furthermore, strict reimbursement outlines for the high costs of endoprosthesis implants in several countries restrain the acquisition rate. This crashed on overall growth of the market. Difficulties, such as implant rejection, implant failure, infections, etc. regarding endoprosthesis implant processes can hinder patients from undergoing such treatments.

Market Segmentation

The global endoprosthesis market share is classified into product and end-user.

• The knee segment is anticipated to hold the largest share of the global endoprosthesis market during the forecast period.    

On the basis of the product, the global endoprosthesis market is divided into knee, hip, shoulder, elbow, finger/hand, and ankle/foot. Among these, the knee segment is anticipated to hold the largest share of the global endoprosthesis market during the forecast period. Because of the alarmingly high rate of obesity and the rapidly aging population, there is a rise in the need for knee replacement surgery. According to the Arthritis Foundation, the age group between 55 and 64 has the largest annual incidence of osteoarthritis in the knee in the United States.

• The hospitals segment is anticipated to hold the highest share of the endoprosthesis market during the forecast period.

On the basis of the end-user, the endoprosthesis market is divided into hospitals, ambulatory surgical centers, and clinics. Among these, the hospitals segment is anticipated to hold the highest share of the endoprosthesis market during the forecast period. A sizable percentage of the market's consumers are hospitals, which serve as the main hubs for complicated medical operations and treatments. They provide a wide range of orthopedic operations employing endoprostheses, as well as specialist surgical facilities prepared to manage these procedures.

Regional Segment Analysis of the Global Endoprosthesis Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global endoprosthesis market over the predicted timeframe.

North America is anticipated to hold the largest share of the global endoprosthesis market over the predicted timeframe. The expansion of the market in North America is attributed to the high cases of cardiovascular diseases and the rising geriatric population. The region is predicted to maintain its dominance over the forecast period due to several factors, including favorable reimbursement policies, rising rates of osteoarthritis and rheumatoid arthritis, well-established healthcare facilities, and a high adoption rate for advanced technological devices. Furthermore, the aging population, which is more prone to joint problems, is expected to contribute to growth. These factors expand the endoprosthesis market over the predicted timeframe in this region.

Asia Pacific is anticipated to grow at the fastest rate in the global endoprosthesis market over the predicted timeframe. The growth of the market in Asia Pacific is attributed to rising awareness regarding endoprosthesis implants and enhancing healthcare facilities in developing markets, such as India and China. Consequently, market expansion in the area is expected to increase in parallel with increases in healthcare spending and hospital frequency. Furthermore, the endoprosthesis market in China had the most market share, while the endoprosthesis market in India had the quickest rate of growth in the Asia-Pacific area. These factors expand the endoprosthesis market over the predicted timeframe in the Asia Pacific region.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global endoprosthesis market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Zimmer Biomet Holdings Inc.
• Smith & Nephew
• Medacta International SA
• MicroPort Orthopedics, Inc.
• B. Braun Melsungen AG
• Johnson & Johnson Services, Inc.
• Stryker
• Corin Ltd
• Exactech, inc.
• Baumer S.A.
• Medtronic
• BD
• Abbott Laboratories
• Boston Scientific
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In September 2022, Zimmer Biomet, a medical technology collaborated with Surgical Planning Associates to merge personalized 3D printing technology for joint replacement surgeries. This fusion aids in enhancing patient results.

• In February 2022, Edwards Lifesciences, patient-focused medical inventions for structural heart disorder received U.S. Food and Drug Administration (FDA) acceptance for its PASCAL Transcatheter Valve Repair System to treat patients with mitral regurgitation. This minimal-invasive system amends valve repair.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the endoprosthesis market based on the below-mentioned segments: 

Global Endoprosthesis Market, By Product

• Knee
• Hip
• Shoulder
• Elbow
• Finger/Hand
• Ankle/Foot

Global Endoprosthesis Market, By End-User

• Hospitals
• Ambulatory Surgical Centers
• Clinics

Global Endoprosthesis Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa